Infojustice Roundup Intellectual Property and the Public Interest Federal Research Public Access Act attracts two dozen additional co-sponsors Twenty four additional Representatives have cosponsored the Federal Research Public Access Act, (FPRAA, H.R.4004), introduced by Rep. Doyle on February 9. The…
On Wednesday, the Indian Supreme Court will hear arguments in Novartis’ challenge to India’s patent law. In 2006, the Indian Patent Office rejected Novartis’ patent application for the cancer drug Glivec (imatinib mesylate), saying that the drug was a new…
Carolina Botero has called attention to the Colombian process of implementing the copyright provisions of the US-FTA. The draft legislation made for implementing these provisions is in a high-speed race. It was presented to the Congress in March 21 and…
On February 29, the PIJIP office submitted several Freedom of Information Act requests to the United States Trade Representative to gather more information on the current procedure for compiling Special 301 Reports. Among them was a general request for…
Today, the European Parliament Committee on Civil Liberties, Justice, and Home Affairs held a debate on ACTA [Webcast]. Tomorrow, the debate will move to the Committee on International Trade [Webcast]. In advance, civil society groups have issued the following statements…
Below is the Statement of the Grupo de Trabalho Sobre, Propriedade Intelectual on the Brazlian government’s decision to annul Abbott Laboratories’ patent on lopinavir+ritonavir, an important antiretroviral medicine for the treatment of HIV The statement was originally released on the…